The Frequency of ANA-positivity and Inflammatory Markers in COVID-19

Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 1

Abstract

Background: Immune system activation plays an important role in pathogenesis and mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The inflammatory response during the disease is caused by the innate and adaptive immune systems. Anti-nuclear antibody (ANA) positivity rate increases in SARS-CoV-2-positive patients due to adaptive immune system activation. This study aims to investigate the association between ANA-positivity rate and pulmonary symptoms, and inflammatory markers (C-reactive protein [CRP] and fibrinogen). Material and Methods: One hundred five consecutive patients with the diagnosis of COVID-19 were included in this cross-sectional study. Participants were divided into groups according to the ANA and pulmonary symptom status. Clinical (gender, age) and biochemical (hemogram, liver function tests, kidney function tests, D-Dimer, CRP, and fibrinogen) were compared between the groups and the impact of ANA positivity on pulmonary symptoms development was assessed. Results: Of the 105 patients, 60 of them had no pulmonary symptoms. The remaining 45 patients had at least one pulmonary symptom. ANA immunofluorescence assay (IFA) positivity rate was 19% (20/105 patients) in the study group. 60% of the ANA-positive patients were positive at 1/160, 30% at 1/320 and 10% at 1/1000 titer. ANA-IFA positivity rate was found higher among patients with pulmonary symptoms; however, the difference was not statistically significant (26.7% vs. 8/60 13.3%, respectively; p=.085). The CRP and fibrinogen levels were (6.9 vs. 3.4, p=.132, and 346.5 vs. 326, p=.183) among ANA positive and negative patients. Twelve (63.2%) patients with ANA-positivity had pulmonary symptoms, and 33 (39.3%) patients with ANA-negativity had pulmonary symptoms (p=0.058).Conclusions: Although there is no difference between patients with or without pulmonary symptoms, ANA, which may reflect the pathogenetic role of adaptive immune dysregulation, can often be detected in patients with Coronavirus disease 2019.

Authors and Affiliations

Tugba Izci Duran1, Melih Pamukcu2, Sanem Kayhan3, Ismet Battal4, Mehmet Derya Demirag5

Keywords

Related Articles

The Effect of Hot Pepper, Sumac, and Chewing on Gastric inhibitory peptide, Glucagon-like Peptide, and Cholecystokinin Hormone Secretion

Background: The influence of various dietary factors on metabolic responses and gastrointestinal function has been the subject of extensive research. In this study, we aimed to investigate the effects of capsaicin, chewi...

A Rare Complication in a Peritoneal Dialysis Patient: Hydrothorax in Late Period

Peritoneal dialysis (PD) associated hydrothorax is a rare complication caused by leakage of dialysis fluid from the peritoneal cavity into the pleural space. The typical clinical presentation is a right-sided pleural eff...

Prognostic Value of Systemic Immune Inflammation Index in Malignant Ischemic Stroke: A Study on Patient Selection and Timing of Surgical Decompression

Background: Ischemic stroke is a substantial health concern with long-term neurological consequences and economic implications. Inflammation worsens secondary brain injury, prompting the search for prognostic biomarkers....

Neuromuscular Dysfunction and Electrophysiological Findings in Patients With Hypothyroidism and Hyperthyroidism

Background: We aimed to determine the frequency of neuropathy and myopathy in newly diagnosed hypothyroid and hyperthyroid patients and to investigate the correlation between serum creatine kinase (CK) concentration and...

Diagnosis and Treatment of Monogenic Hypertension in Children

Hypertension (HT) is a common public health problem that develops due to primary and secondary causes. The prevalence of HT in children and adolescents is 3.6%. In childhood HT, complex and polygenic factors such as gene...

Download PDF file
  • EP ID EP713723
  • DOI https://doi.org/10.5281/zenodo.7562171
  • Views 67
  • Downloads 0

How To Cite

Tugba Izci Duran1, Melih Pamukcu2, Sanem Kayhan3, Ismet Battal4, Mehmet Derya Demirag5 (2023). The Frequency of ANA-positivity and Inflammatory Markers in COVID-19. Journal of European Internal Medicine Professionals (JEIMP), 1(1), -. https://europub.co.uk/articles/-A-713723